Máster en Alimentación, Ética y Derecho

Cátedra UNESCO de Bioética

Contacto

 

"The Neuralink Patient Behind the Musk"

The Hastings Center

The sole virtue of Elon Musk’s report on X, formerly known as Twitter, of the first in-human brain implant by his company, Neuralink, is its brevity: “The first human received an implant from Neuralink yesterday and is recovering well. Initial results show promising neuron spike detection.” But, in this case, that virtue is very limited. Brevity is not so admirable in novel human research. Opening up the brain of a living human being to insert a device, particularly someone with serious medical problems, deserves more than a two-sentence report on what is, in effect, a proprietary social media platform not distinguished for its reliability where facts are concerned.